The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

AmSurg Corp

Nasdaq: AMSG
Last

(U.S.) $67.34

Today's change+0.17 +0.25%
Updated May 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

AmSurg Corp

Nasdaq: AMSG
Last

(U.S.) $67.34

Today's change+0.17 +0.25%
Updated May 29 4:00 PM EDT. Delayed by at least 15 minutes.

AmSurg Corp up (U.S.)$0.17

AmSurg Corp closed up Friday by (U.S.)$0.17 or 0.25% to (U.S.)$67.34. Shares have lost 1.65% over the last five days, but sit 3.59% below their 52-week high. This security has outperformed the S&P 500 by 37.47% during the last year.

Key company metrics

  • Open(U.S.) $67.07
  • Previous close(U.S.) $67.17
  • High(U.S.) $67.86
  • Low(U.S.) $66.08
  • Bid / Ask-- / --
  • YTD % change+23.04%
  • Volume336,345
  • Average volume (10-day)306,426
  • Average volume (1-month)328,977
  • Average volume (3-month)342,419
  • 52-week range(U.S.) $44.33 to (U.S.) $69.85
  • Beta1.14
  • Trailing P/E65.85×
  • P/E 1 year forward20.04×
  • Forward PEG1.09×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.02
Updated May 29 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.18%

Based on its net profit margin of 13.18%, AmSurg Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.62%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue570579503281
Total other revenue--------
Total revenue570579503281
Gross profit528536461240
Total cost of revenue43434241
Total operating expense457448408193
Selling / general / administrative30429326685
Research & development--------
Depreciation / amortization2323219
Interest expense (income), net operating--------
Unusual expense (income)000-1
Other operating expenses, total91938260
Operating income1131329588
Interest income (expense), net non-operating-30-30-39-7
Gain (loss) on sale of assets--------
Other--------
Income before tax831013981
Income after tax69793968
Income tax, total1422013
Net income2127-1019
Total adjustments to net income-2-2-2--
Net income before extra. items2127-819
Minority interest-48-52-47-49
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1925-1019
Inc. avail. to common incl. extra. items1925-1219
Diluted net income1925-1219
Dilution adjustment--000
Diluted weighted average shares48474632
Diluted EPS excluding extraordinary itemsvalue per share0.390.53-0.220.59
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.400.53-0.220.55